HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 202 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q3 2023. The put-call ratio across all filers is 0.36 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,022,299 | +307.3% | 57,468 | +277.9% | 0.05% | +278.6% |
| Q1 2023 | $496,574 | -72.9% | 15,209 | -54.3% | 0.01% | -73.1% |
| Q4 2022 | $1,832,681 | +349.2% | 33,261 | +261.0% | 0.05% | +271.4% |
| Q3 2022 | $408,000 | -46.2% | 9,214 | -40.8% | 0.01% | -58.8% |
| Q2 2022 | $759,000 | +3.8% | 15,558 | +3.5% | 0.03% | 0.0% |
| Q1 2022 | $731,000 | +16.8% | 15,028 | +2.4% | 0.03% | -12.8% |
| Q4 2021 | $626,000 | -20.2% | 14,674 | -28.3% | 0.04% | -37.1% |
| Q3 2021 | $784,000 | +148.1% | 20,460 | +82.9% | 0.06% | +129.6% |
| Q2 2021 | $316,000 | – | 11,188 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $366,268,777 | 96.46% |
| venBio Partners LLC | 1,035,396 | $33,805,679 | 18.74% |
| Nan Fung Group Holdings Ltd | 368,665 | $12,036,912 | 8.19% |
| Vivo Capital, LLC | 2,606,247 | $85,093,965 | 5.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 570,500 | $18,621,120 | 5.20% |
| ASHFORD CAPITAL MANAGEMENT INC | 445,418 | $14,542,898 | 2.18% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 678,715 | $22,160,045 | 2.07% |
| TANG CAPITAL MANAGEMENT LLC | 321,200 | $10,487,180 | 1.56% |
| AlphaCentric Advisors LLC | 67,500 | $2,203,875 | 1.52% |
| Paradiem, LLC | 66,995 | $2,187,387 | 0.68% |